Effects of Hydrogen Sulfide-releasing l-DOPA Derivatives on Glial Activation: POTENTIAL FOR TREATING PARKINSON DISEASE

The main lesion in Parkinson disease (PD) is loss of substantia nigra dopaminergic neurons. Levodopa (l-DOPA) is the most widely used therapy, but it does not arrest disease progression. Some possible contributing factors to the continuing neuronal loss are oxidative stress, including oxidation of l...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Lee, Moonhee, Tazzari, Valerio, Giustarini, Daniela, Rossi, Ranieri, Sparatore, Anna, Del Soldato, Piero, McGeer, Edith, McGeer, Patrick L.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Biochemistry and Molecular Biology 2010
Assuntos:
Molecular Bases of Disease
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2878495/
https://ncbi.nlm.nih.gov/pubmed/20368333
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1074/jbc.M110.115261
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados